Danaher Corporation Total Assets

Latest as of September 2025: $79.90 Billion USD

Danaher Corporation total assets. Based on the latest financial reports, Danaher Corporation (DHR) holds total assets worth $79.90 Billion USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Danaher Corporation market cap and net worth for the company's overall valuation and market capitalisation.

Total Assets of Danaher Corporation (1985–2024)

Total assets of Danaher Corporation from 1985 to 2024. This chart illustrates how Danaher Corporation's total assets have evolved over time, based on quarterly financial data. See Danaher Corporation (DHR) stock price for real-time trading data and today's change.

Danaher Corporation - Asset Composition Analysis

Danaher Corporation Total Assets Breakdown (December 2024)

Danaher Corporation total assets breakdown as of December 2024. Danaher Corporation's total assets of $79.90 Billion consist of 12.3% current assets and 87.8% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $2.08 Billion 2.7%
Accounts Receivable $4.39 Billion 5.7%
Inventory $2.33 Billion 3.0%
Property, Plant & Equipment $6.07 Billion 7.8%
Intangible Assets $18.57 Billion 24.0%
Goodwill $40.50 Billion 52.2%

Asset Composition Trend (1985–2024)

This chart illustrates how Danaher Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Danaher Corporation (DHR) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Danaher Corporation's current assets represent 12.3% of total assets in 2024, a decrease from 65.6% in 1985.
  • Cash Position: Cash and equivalents constituted 2.7% of total assets in 2024, down from 35.2% in 1985.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 75.0% of total assets, an increase from 8.0% in 1985.
  • Asset Diversification: The largest asset category is goodwill at 52.2% of total assets.

Danaher Corporation Competitors by Total Assets

Key competitors of Danaher Corporation based on total assets are shown below.

Company Country Total Assets
Revvity Inc.
NYSE:RVTY
USA $12.00 Billion
Diagnósticos da América S.A
SA:DASA3
Brazil R$21.10 Billion
SMO ClinPlus Co. Ltd.
SHE:301257
China CN¥1.52 Billion
Monash Ivf Group Ltd
AU:MVF
Australia AU$512.35 Million
RHYTHM Biosciences Ltd
AU:RHY
Australia AU$3.10 Million
Bcal Diagnostics Ltd
AU:BDX
Australia AU$7.66 Million
Sonic Healthcare Ltd
AU:SHL
Australia AU$16.78 Billion
Integral Diagnostics Ltd
AU:IDX
Australia AU$1.43 Billion

Danaher Corporation - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.52 1.37 1.86
Quick Ratio 1.10 1.01 1.55
Cash Ratio 0.24 0.36 0.00
Working Capital $3.28 Billion $2.72 Billion $6.40 Billion

Danaher Corporation - Advanced Valuation Insights

This section examines the relationship between Danaher Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 3.25
Latest Market Cap to Assets Ratio 2.14
Asset Growth Rate (YoY) -8.2%
Total Assets $77.54 Billion
Market Capitalization $165.94 Billion USD

Valuation Analysis

Premium Asset Valuation: The market values Danaher Corporation's assets at a significant premium (2.14x), suggesting investors see substantial growth potential or unique competitive advantages.

Significant Asset Reduction: Danaher Corporation's assets decreased by 8.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Danaher Corporation (1985–2024)

The table below shows the annual total assets of Danaher Corporation from 1985 to 2024.

Year Total Assets Change
2024-12-31 $77.54 Billion -8.22%
2023-12-31 $84.49 Billion +0.16%
2022-12-31 $84.35 Billion +1.40%
2021-12-31 $83.18 Billion +9.22%
2020-12-31 $76.16 Billion +22.68%
2019-12-31 $62.08 Billion +29.79%
2018-12-31 $47.83 Billion +2.54%
2017-12-31 $46.65 Billion +2.99%
2016-12-31 $45.30 Billion -6.07%
2015-12-31 $48.22 Billion +30.36%
2014-12-31 $36.99 Billion +6.69%
2013-12-31 $34.67 Billion +5.26%
2012-12-31 $32.94 Billion +9.99%
2011-12-31 $29.95 Billion +34.80%
2010-12-31 $22.22 Billion +13.38%
2009-12-31 $19.60 Billion +12.04%
2008-12-31 $17.49 Billion +0.10%
2007-12-31 $17.47 Billion +35.82%
2006-12-31 $12.86 Billion +40.39%
2005-12-31 $9.16 Billion +7.88%
2004-12-31 $8.49 Billion +23.28%
2003-12-31 $6.89 Billion +14.28%
2002-12-31 $6.03 Billion +25.07%
2001-12-31 $4.82 Billion +19.57%
2000-12-31 $4.03 Billion +32.31%
1999-12-31 $3.05 Billion +11.26%
1998-12-31 $2.74 Billion +45.70%
1997-12-31 $1.88 Billion +6.49%
1996-12-31 $1.77 Billion +18.78%
1995-12-31 $1.49 Billion +30.94%
1994-12-31 $1.13 Billion +30.07%
1993-12-31 $872.50 Million +13.34%
1992-12-31 $769.80 Million +4.73%
1991-12-31 $735.00 Million -1.28%
1990-12-31 $744.50 Million +46.79%
1989-12-31 $507.20 Million -11.91%
1988-12-31 $575.80 Million -12.13%
1987-12-31 $655.30 Million -11.53%
1986-12-31 $740.70 Million +175.46%
1985-12-31 $268.90 Million --

About Danaher Corporation

NYSE:DHR USA Diagnostics & Research
Market Cap
$165.94 Billion
Market Cap Rank
#138 Global
#79 in USA
Share Price
$234.93
Change (1 day)
+2.09%
52-Week Range
$161.91 - $242.05
All Time High
$290.97
About

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the deve… Read more